Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALB | P02768 | 1/20 | 1.00 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.43 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.40 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.37 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.37 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.37 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.37 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.37 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.37 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.37 |
| ▸ | MAOB | P27338 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.36 |
| ▸ | EGFR | P00533 | 1/20 | 0.35 |
| ▸ | SRC | P12931 | 1/20 | 0.35 |
| ▸ | DAO | P14920 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6262748 | 1.00 | ALB (1.00) | ALBMCL1TRPA1GRIN2DGRIN3B | |
| SCHEMBL6274908 | 0.88 | ALB (0.78) | ALBMCL1TRPA1GRIN2DGRIN3B | |
| SCHEMBL6274906 | 0.88 | ALB (0.78) | ALBMCL1TRPA1GRIN2DGRIN3B | |
| SCHEMBL6636740 | 0.76 | ALB (0.61) | ALBMCL1TRPA1GRIN2DGRIN3B | |
| SCHEMBL6636737 | 0.76 | ALB (0.61) | ALBMCL1TRPA1GRIN2DGRIN3B | |
| SCHEMBL6818878 | 0.72 | ALB (0.56) | ALBMCL1TRPA1MEN1KMT2A | |
| SCHEMBL7326492 | 0.70 | MCL1 (0.54) | ALBMCL1GRIN2DGRIN3BGRIN1 | |
| SCHEMBL7326486 | 0.70 | MCL1 (0.54) | ALBMCL1GRIN2DGRIN3BGRIN1 | |
| SCHEMBL6995099 | 0.69 | ADORA2A (0.56) | ALBMCL1TRPA1GRIN2DGRIN3B | |
| SCHEMBL6995096 | 0.69 | ADORA2A (0.56) | ALBMCL1TRPA1GRIN2DGRIN3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1583965-A1 | METHOD FOR DETERMINING MOLECULAR AFFINITIES FOR HUMAN SERUM ALBUMIN | Pharmacia & Upjohn Company LLC (US) | 2005-10-12 | — | — | EP | claimed |
| US-20050003449-A1 | Method for determining molecular affinities for human serum albumin | PHARMACIA & UPJOHN COMPANY | 2005-01-06 | — | — | US | claimed |
| WO-2004063749-A1 | METHOD FOR DETERMINING MOLECULAR AFFINITIES FOR HUMAN SERUM ALBUMIN | PHARMACIA & UPJOHN COMPANY LLC (US) | 2004-07-29 | — | — | WO | claimed |
| EP-1583965-A1 | METHOD FOR DETERMINING MOLECULAR AFFINITIES FOR HUMAN SERUM ALBUMIN | Pharmacia & Upjohn Company LLC (US) | 2005-10-12 | — | — | EP | disclosed |
| US-20050003449-A1 | Method for determining molecular affinities for human serum albumin | PHARMACIA & UPJOHN COMPANY | 2005-01-06 | — | — | US | disclosed |
| WO-2004063749-A1 | METHOD FOR DETERMINING MOLECULAR AFFINITIES FOR HUMAN SERUM ALBUMIN | PHARMACIA & UPJOHN COMPANY LLC (US) | 2004-07-29 | — | — | WO | disclosed |
| US-20040110802-A1 | Antibacterial benzoic acid derivatives | PHARMACIA & UPJOHN COMPANY | 2004-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040110802-A1 | Antibacterial benzoic acid derivatives | GABRD, GABBR1, GABRA1 | ALB 1417/4885MCL1 2086/4885TRPA1 377/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.